Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like Pfizer's $15B Consumer Health Biz May be on GlaxoSmithKline's Shopping List October 25, 2017 Two Bay Area Diagnostic Companies Win Amgen's Golden Ticket July 11, 2017 How High Novo Nordisk Could and Should Go for Ablynx January 23, 2018